• Molecular NameDapiprazole
  • SynonymN/A
  • Weight325.46
  • Drugbank_IDDB00298
  • ACS_NO72822-12-9
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.72
  • pkaN/A
  • LogD (pH=7, predicted)1.93
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.72
  • LogSw (predicted, AB/LogsW2.0)1.6
  • Sw (mg/ml) (predicted, ACD/Labs)0.04
  • No.of HBond Donors0
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds4
  • TPSA37.19
  • StatusFDA approved
  • AdministrationTopical (eye drops)
  • PharmacologyAn alpha blocker. It is used to reverse mydriasis after eye examination.
  • Absorption_value0.0
  • Absorption (description)Systemic absorption is negligible.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)1189~2100 mg/kg
  • LD50 (mouse)N/A